Alternative Investing
Independent of Economic Cycles
For global investors, the Fund represents an alternative investment vehicle that provides an attractive diversification option. With a focus on advancing our investments through proof-of-concept, the Fund’s returns are driven by the ever-increasing demand from pharmaceutical companies for innovative and commercially attractive products in areas of high unmet medical need. As such, the Fund’s economics are largely independent of the state of global financial markets or economic cycles.